Skip to main content
Log in

Eosinophilia in a peritoneal dialysis patient: Answers

  • Clinical Quiz
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Icodextrin is a starch-derived glucose polymer used in peritoneal dialysis dialysate to treat volume overload by increasing ultrafiltration in patients with end-stage renal disease. Reported adverse reactions to icodextrin are mild and rare and mainly consist of skin rash that resolves spontaneously after discontinuation of treatment. We describe a young patient with extreme eosinophilia that appeared with the use of icodextrin, disappeared after its discontinuation, and reappeared after a rechallenge with the drug. The eosinophilia was not associated with peritonitis, was asymptomatic, and fully resolved after discontinuation of the drug. Severe eosinophilia can potentially cause tissue damage in several organs, which would indicate that blood eosinophil count is recommended in routine complete blood counts while icodextrin peritoneal dialysis is being administered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chandran PK, Humayun HM, Daugirdas JT, Nawab ZM, Gandhi VC, Ing TS (1985) Blood eosinophilia in patients undergoing maintenance peritoneal dialysis. Arch Intern Med 145:114–116

    Article  PubMed  CAS  Google Scholar 

  2. Patel UO, Fox SR, Moy JN, Korbet SM (2011) Pruritic rash and eosinophilia in a patient receiving peritoneal dialysis. Semin Dial 24:338–340

    Article  PubMed  Google Scholar 

  3. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimbürger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC (2003) Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 14:2338–2344

    Article  PubMed  CAS  Google Scholar 

  4. Canepa A, Verrina E, Perfumo F (2008) Use of new peritoneal dialysis solutions in children. Kidney Int Suppl :S137-144

  5. MacGinley R, Cooney K, Alexander G, Cohen S, Goldsmith DJ (2002) Relapsing culture negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution. Am J Kidney Dis 40:1030–1035

    Article  PubMed  CAS  Google Scholar 

  6. Martis L, Patel M, Giertych J, Mongoven J, Taminne M, Perrier MA, Mendoza O, Goud N, Costigan A, Denjoy N, Verger C, Owen WF Jr (2005) Aseptic peritonitis due to peptidoglycan contamination of pharmacopeia standard dialysis solution. Lancet 365:588–594

    Article  PubMed  CAS  Google Scholar 

  7. Chan MK, Chow L, Lam SS, Jones B (1988) Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis 11:180–183

    Article  PubMed  CAS  Google Scholar 

  8. Roufosse F, Weller PF (2010) Practical approach to patient with hypereosinophilia. J Allergy Clin Immunol 126:39–44

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shimrit Tzvi-Behr.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

This refers to the article that can be found at https://doi.org/10.1007/s00467-017-3845-7.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tzvi-Behr, S., Frishberg, Y., Ben-Shalom, E. et al. Eosinophilia in a peritoneal dialysis patient: Answers. Pediatr Nephrol 33, 1507–1508 (2018). https://doi.org/10.1007/s00467-017-3847-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-017-3847-5

Keywords

Navigation